Clinical Trial

A Study of SYS6051 in Subjects With Advanced Solid Tumors

Name: A Study of SYS6051 in Subjects With Advanced Solid Tumors — clinical trial record (NCT07591285)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label, dose-escalation and backfill, and cohort-expansion phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor efficacy of SYS6051 in participants with advanced solid tumors.

Trial Details

NCT Number	NCT07591285
Lead Sponsor	CSPC Megalith Biopharmaceutical Co.,Ltd.
Conditions	Advanced Solid Tumors
Enrollment	114 participants
Start Date	2026-05-12
Primary Completion	2028-05-31 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-15